This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
March 11/Heart Disease Weekly -- A new study by researchers at Harvard Medical School has found that combining essential B vitamins, including B6, B12 and folic acid, lower the risk of developing age-related macular degeneration (AMD), one of the leading causes of vision loss among older Americans. These ingredients are formulated in combination with key omega-3 fatty acids and phytosterols.
In the randomized, double-blind clinical trial, more than 5,000 women with heart disease, and at least three risk factors for cardiovascular disease, were given vitamins B6, B12 and folic acid over a seven-year time period. At the end of the trial, approximately 34% of the women had a lower risk of developing any type of AMD, while 41% had a lower risk of more severe forms of AMD.